733464008: Ocrelizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Ocrelizumab

\Drug or medicament (substance)\Immunologic agent (substance)\Ocrelizumab
\Drug or medicament (substance)\Monoclonal antibody\Ocrelizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ocrelizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ocrelizumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Ocrelizumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Ocrelizumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Ocrelizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3499483013 Ocrelizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3499484019 Ocrelizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3499483013 Ocrelizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3499484019 Ocrelizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

50661000195118 ocrelizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

64711000195111 Ocrelizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

828991000172114 ocrélizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

828991000172114 ocrélizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

50661000195118 ocrelizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

64711000195111 Ocrelizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ocrelizumab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ocrelizumab	Is a	Immunomodulator	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ocrelizumab	Has disposition	Immunomodulator (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ocrelizumab	Is a	Immunologic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing ocrelizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ocrelizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Ocrelizumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ocrelizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Ocrelizumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ocrelizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only ocrelizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ocrelizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Ocrelizumab therapy (procedure)	Direct substance	True	Ocrelizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets